Bill Anderson
Chairman of the Board of Management and Chief Executive OfficerBayer
PharmaceuticalsView Profile →Executive Vice President, US Operations · Novo Nordisk
Jamey Millar leads Novo Nordisk’s US operations, following leadership in pharmaceuticals, market access and specialty healthcare services.
Last reviewed: Nov 15, 2026
Jamey Millar leads Novo Nordisk’s US operations, following leadership in pharmaceuticals, market access and specialty healthcare services.
Millar began his career at Procter & Gamble Pharmaceuticals, working in the United States and the United Kingdom. His assignments included general management for the UK, Netherlands and Ireland. He later spent twenty years at GlaxoSmithKline, developing experience in commercial operations and market access.
At GSK, he led the US oncology business as vice president and general manager and served as senior vice president for Managed Markets and Government Affairs. His work encompassed pharmaceutical launches, payer strategy and the commercial planning of medicines across chronic diseases and specialty treatments.
He subsequently moved to UnitedHealth Group, where he led Industry Relations at OptumRx. That remit included manufacturer contracting, formulary management, wholesaler and pharmacy agreements, and Optum Life Sciences. As CEO of Optum Specialty Holdings, he worked on building and expanding specialty distribution and biosimilars businesses.
Millar joined Novo Nordisk in February 2026 as executive vice president for US Operations. The appointment brought his pharmaceutical, payer and distribution experience into leadership of the company’s largest sales region. He earned a bachelor’s degree in English literature at Hamilton College in 1990.